Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference

LIBERTY® Continues to Gain Commercial Traction and Exposure as Part of Its Limited Market Release (LMR) in the US ...

This Microbot Medical analyst begins coverage on a bullish note; here are top 2 initiations for Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...
Nasdaq

Microbot Medical Inc. Announces Registered Direct Offering and Concurrent Private Placement Totaling Approximately $13 Million

Microbot Medical Inc. announces a direct offering of common stock and a concurrent private placement, raising approximately $13 million. Microbot Medical Inc. announced a registered direct offering ...
Business Insider

Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones

Limited Market Release (LMR) of the LIBERTY ® System is on Schedule Building on Positive Customer Feedback and Growing Market Enthusiasm, the Company Prepares for Full Market Release (FMR) in Q2 ...

Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption

Participating at the Society of Interventional Oncology Conference Will Allow the Company to Share Practical Insights and Personal ExperiencesHINGHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Microbot ...
Fintel on MSN

B Riley Securities initiates coverage of Microbot Medical (MBOT) with buy recommendation

Fintel reports that on February 10, 2026, B. Riley Securities initiated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 315.76% Upside As of ...
Nasdaq

Microbot Medical Appoints the Co-Founder of Corindus Vascular Robotics to its Board of Directors

HINGHAM, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has further strengthened the Company’s capabilities and expertise as Mr. Tal Wenderow, an experienced medical ...
Seeking Alpha

Microbot Medical® Strengthens Its Management Team in Support of the Anticipated Commercial Launch of LIBERTY®

BRAINTREE, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, today announced the appointment of Ms. Michal ...
Yahoo Finance

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales

HINGHAM, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced the appointment of Christina Bailey ...
MarketWatch

REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

The MarketWatch News Department was not involved in the creation of this content. HINGHAM, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of ...
The National Law Review

Microbot Medical Closes $13 Million Registered Direct Offering

BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering priced at-the-market under ...